Abstract: In multivariate regression analyses, rs4938723 in dominant model increased
HCC risk (AOR = 1.62, 95% CI = 1.05-2.49), whereas its multiplicative interaction with
C1730G, a HBV mutation inversely associated with
HCC risk, reduced
HCC risk (AOR = 0.34, 95% CI = 0.15-0.81); rs11614913 strengthened the
G1896A effect but attenuated the
A3120G/T effect on
HCC risk.
Result: In those with the data of HBV mutations in the
preS region, pri-miR-34b/c rs4938723 in dominant genetic model was significantly associated with an increased risk of
HCC whereas its int